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ABSTRACT
Arsenic and benzo[a]pyrene (B[a]P) are common contaminants in developing 
countries. Many studies have investigated the consequences of arsenic and/
or B[a]P-induced cellular transformation, including altered metabolism. In the 
present study, we show that, in addition to elevated glycolysis, B[a]P/arsenic-induced 
transformation also stimulates oxidative phosphorylation (OXPHOS). Proteomic data 
and immunoblot studies demonstrated that enzymatic activities, involved in both 
glycolysis and OXPHOS, are upregulated in the primary transformed rat lung epithelial 
cell (TLEC) culture, as well as in subcloned TLEC cell lines (TMCs), indicating that 
OXPHOS was active and still contributed to energy production. LEC expression, of 
the glycolytic enzyme phosphoglycerate mutase (PGAM) and the TCA cycle enzyme 
alpha-ketoglutarate dehydrogenase (OGDH), revealed an alternating cyclic pattern of 
glycolysis and OXPHOS during cell transformation. We also found that the expression 
levels of hypoxia-inducible factor-1a were consistent with the pattern of glycolysis 
during the course of transformation. Low doses of an ATP synthase inhibitor depleted 
endogenous ATP levels to a greater extent in TLECs, compared to parental LECs, 
indicating greater sensitivity of B[a]P/arsenic-transformed cells to ATP depletion. 
However, TLEC cells exhibited better survival under hypoxia, possibly due to further 
induction of anaerobic glycolysis. Collectively, our data indicate that B[a]P/arsenic-
transformed cells can maintain energy production through upregulation of both 
glycolysis and OXPHOS. Selective inhibition of metabolic pathways may serve as a 
therapeutic option for cancer therapy.
INTRODUCTION
Benzo[α]pyrene and arsenic derivatives are 
ubiquitously distributed in our environment [1–4], 
leading to wide-spread human exposure [5–10]. People 
living in contaminated areas have a high risk of getting 
various cancers [1, 2, 9, 11–14]. Various experimental 
models have been developed to understand how arsenic 
alone causes cancers [15–17], but these models are not 
comprehensive because arsenic alone is a weak carcinogen 
[17, 18] and cannot provide a complete understanding of 
the rising cancer incidence in areas chronically exposed 
to arsenic and B[a]P. Previously, our group revealed that 
the combined action of B[a]P and arsenic is 100-fold 
more tumorigenic than B[a]P or arsenic alone [18, 19]. 
Tumorigenicity of cells was confirmed by anchorage-
independent growth and the ability to form tumors in nude 
mice. Using the SELDI-TOF Protein Chip, we were able 
to detect significant alterations of protein expression in 
transformed rat lung cells (TLECs), compared to parental 
LECs, with most of the altered proteins belonging to 
metabolic pathways [18]. Most cancer cells display up-
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regulation of glycolysis for fast production of ATP. This 
phenomenon was discovered 80 years ago and termed the 
“Warburg effect” [20]. A change in glucose metabolism 
has been implicated as a key contributor to malignant 
progression [21–23]. However, how this glycolytic switch 
happens, and whether it is a cause or a consequence has 
remained a matter of debate.
An increase in aerobic glycolysis does not mean 
that OXPHOS is deficient. Recent reports indicate that 
cancer cells preferring aerobic glycolysis show functional 
mitochondria, and that cancer cells can restore OXPHOS 
when glycolysis is inhibited [24–27]. Other reports also 
reveal that some cancers are more sensitive to inhibition of 
OXPHOS than inhibition of glycolysis [27, 28], indicating 
aerobic glycolysis is not a must for cancer cells. Due to the 
heterogeneity and plasticity of cancer cells, it is possible 
that such cancer cells rely more heavily on OXPHOS 
under normoxic conditions, and switch to glycolysis under 
hypoxic conditions.
RESULTS
B[a]P/Arsenic-induced lung epithelial cell 
transformation
Lung epithelial cell (LEC) transformation was 
induced by our previously-established transformation 
protocol [18, 19]. Transformation of LECs was evident 
by anchorage-independent growth in soft agar (Figure 
1A). Transformed LECs (TLECs) gave an average of 
20 colonies per well (seeded at 5 x 104 cells per well) 
and the average diameter of the colonies was about 
0.2 mm. In contrast, no colonies were observed upon 
inoculation of control LECs in soft agar. Morphologically, 
TLECs were characterized by a large nucleus, increased 
nucleus/cytoplasm ratio, and irregular size and shape, 
with movement starting with the formation of irregular 
cytoplasmic pseudopods (Figure 1C).
Figure 1: Morphology and tumorigenic properties of TLECs. A. Soft-agar colony forming assay. Single cell suspensions of both 
LEC and TLEC cell lines were grown in semi-solid soft agar. Colony formation was examined under a microscope and photos were taken 
after incubation for 4 weeks. In the left graph, arrow A indicates a single LEC cell. In the right graph, arrow B points to a colony formed 
from TLEC cells. All images were taken at 200X magnification. B. Tumor formation in immunodeficient nude mice. a) Frequency of tumor 
formation in nude mice five weeks after subcutaneous injection with 5 x 106 LEC or TLEC cells. b) Graphic representation of the percentage 
of nude mice developing tumors showing 60% and none of the mice developed tumors after subcutaneous injection with TLECs and LECs, 
respectively (*, p < 0.05 statistically significant difference compared with the control). C. Morphologies of LECs and TLECs. TLECs have 
larger nuclear size, and possess irregular cell size and shape, showing an aggressive and neoplastic phenotype. Bar = 10 μm.
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The tumorigenic properties of TLECs were studied 
in vivo. TLECs were injected into immunodeficient nude 
mice and examined for tumorigenicity. Five mice received 
subcutaneous injections of an equal number of cells (5 
x 106) of either control LECs or TLECs. Three repeat 
experiments were performed. In total, 8 out of 15 (53.3%) 
of mice injected with TLECs developed subcutaneous 
tumors at the site of injection, whereas none of the mice 
injected with control LECs developed tumors (Figure 
1B). These data confirm the tumorigenic properties of 
TLECs in vivo and demonstrates that arsenic-induced cell 
transformation is a useful model for the characterization of 
events associated with the process of tumorigenesis.
Up-regulation of the ATP synthase alpha-subunit
The protein profiles of parental LECs and TLECs 
were determined by tandem 2-dimensional electrophoresis 
and MALDI-TOF mass spectrometry. Several up-
regulated and down-regulated proteins were detected 
in TLECs compared to LECs. Seven of these proteins, 
whose protein levels altered more than two-fold, are 
listed in Table 1. The proteomic data showed up-regulated 
proteins were involved in both glycolysis and chaperone 
functions (Figure 2A), validating the Warburg effect 
observed in arsenic exposed cells [34]. Apart from these 
glycolytic enzymes, up-regulation of the alpha-subunit of 
ATP synthase was also observed, suggesting that B[a]P/
arsenic-transformed cells require greater ATP production 
due to alteration of enzymatic activities involved in 
both glycolysis and OXPHOS. The proteomic data was 
validated by immunoblotting (Figure 2B).
Arsenic is a known inhibitor of OXPHOS. To 
show that OXPHOS is at least partly intact in TLECs, 
the expression of enzymes involved in OXPHOS was 
compared. SCO2 and OGDH are two important enzymes 
involved in OXPHOS. SCO2 is responsible for catalyzing 
the transfer of electrons from cytochrome c to oxygen 
and pump protons to generate the electrochemical 
gradient across the mitochondrial membrane, while 
OGDH is crucial for catalyzing the conversion of alpha-
ketoglutarate to succinyl-CoA, an intermediate substrate in 
the tricarboxylic acid cycle. These two enzymes were up-
regulated in TLECs (Figure 2C), suggesting that OXPHOS 
was active.
To ensure the increase in protein levels of ATP 
synthase and enzymes involved in OXPHOS reflected an 
increase in their enzymatic activities, we next quantified 
checked the activities of the individual proteins. In this 
experiment, we used an ATP synthase activity kit which 
first captures the ATP synthase complex in the reaction 
wells and then measures the activity by the oxidation 
of NADH to NAD+. Our measurements show that ATP 
synthase activity was enhanced 2.7-fold in TLEC cells 
(Figure 2D). OXPHOS complex I enzyme activity was 
increased by 76% in TLEC cell extracts (Figure 2E).
TLECs are heterogeneous transformed cells and 
each transformed cell may have its individual metabolic 
features. We therefore subcloned TLECs into several 
transformed cell lines designated as TMC1, TMC2, and 
so on. As shown in Figure 2F, their glucose metabolic 
phenotypes varied from one TMC to another. Although 
aerobic glycolysis was favored in TLECs, OXPHOS still 
contributed to energy production in some TMCs, and may 
play a significant role in their energy production (Figure 
2G).
TLECs are susceptible to both inhibition of 
OXPHOS and glycolysis
Our proteomic data revealed that enzymes involved 
in both glycolysis and ATP synthase were up-regulated 
in TLECs, suggesting that both glycolysis and OXPHOS 
were stimulated. To determine if TLECs were susceptible 
to both inhibition of glycolysis and OXPHOS, cellular 
viability was examined after addition of a glycolysis 
inhibitor or OXPHOS inhibitor. 2-Deoxy-D-glucose 
(2DG) is an analog of glucose and able to inhibit glycolysis 
[35]. Sodium azide inhibits cytochrome oxidase, which 
is the complex IV in the electron transport chain, and 
therefore inhibits ATP production from mitochondria [36].
Cytotoxicity was examined in response to increasing 
concentrations of 2DG. A dose-dependent cytotoxicity 
was observed in both LECs and TLECs (Figure 3A). 
Consistent with the literature, arsenic-transformed TLECs 
were more susceptible to inhibition of glucose metabolism 
by 2DG [34], suggesting that TLECs rely more on glucose 
metabolism than parental LECs. To determine cytotoxicity 
towards inhibition of OXPHOS, increasing concentrations 
of sodium azide were added to cells. At concentrations 
above 1 mM, TLECs exhibited significantly more cell 
death compared to LECs (Figure 3B). Together, our 
findings suggest TLECs rely on both glycolysis and ATP 
production from mitochondria.
By comparing the glycolytic enzyme PGAM and 
TCA cycle enzyme OGDH, we also found interesting 
cyclic patterns of glycolysis and OXPHOS in LECs 
during the course of cell transformation. As shown in 
Figure 3C, glycolytic enzymes increased at an early stage 
of transformation, decreased in the midterm, and then 
increased again at a later stage during transformation 
process. The pattern of OXPHOS was the reverse, 
with OGDH levels decreasing initially, then increasing 
significantly during the mid-term of transformation, and 
finally decreasing at the latter stage of progression. This 
phenomenon is consistent with Smolkova et al. [37].
ATP synthase plays an important role in the 
metabolism of TLECs
Our proteomic data and enzymatic activities 
showed an induction of the alpha-subunit of ATP synthase 
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Table 1: Protein alterations in B[a]P/arsenic-transformed vs. parental cells
Spot No. Protein Accession 
No.
MW(Kd)/
pI
Protein 
score/
C.I.%
#protein 
matched/
sequence
Fold difference 
±S.D.
1 Peripherin 166063971 53/5.4 150/100 35/4 −10.94±0.34
2 Cytokeratin 8 40786432 52/5.4 134/100 32/5 − 2.54±0.97
3 Alpha-enolase 158186649 45/6.2 110/100 43/4 + 2.55±0.01
4 Aldose reductase 6978491 36/5.9 183/100 43/20 + 4.35±0.09
5
Phosphoglycerate 
mutase 1
16757984 29/6.7 261/100 48/4 + 6.58±0.58
6 Grp75 10000439 74/5.87 100/100 16/2 + 3.36±0.58
7 Chain A, rat liver 6729934 55/8.28 315/100 20/4 + 6.40±1.14
Figure 2: Representative protein gel images of parental LECs and transformed TLECs. A. Protein pattern of control LECs 
(top) and TLECs (bottom) displayed by 2D gels (12.5%) and silver staining. Arrows identify the spots that were identified by MALDI-TOF 
mass spectrometry and listed in Table 1. B. Immunoblotting to validate the proteins identified by MALDI-TOF mass spectrometry. Total 
cellular proteins of LECs and TLECs were subjected to western blot analysis. After development, the membrane was stripped and re-probed 
with an actin monoclonal antibody to monitor the loading. C. Two enzymes in the OXPHOS pathway, SCO2 and OGDH, were determined 
by western blot analysis. Both SCO2 and OGDH were upregulated in TLECs. Results are representative of three independent experiments. 
(continued )
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in TLECs, and our cytotoxicity test suggested that ATP 
production from mitochondria is important in TLECs. 
We then compared endogenous ATP levels in both LECs 
and TLECs. Consistent with our proteomic findings, 
a higher endogenous ATP level was found in TLECs 
compared to parental LECs (Figure 4A). To determine 
the change in endogenous ATP level after inhibition of 
ATP production by mitochondria, sodium azide and N,N’-
dicyclohexylcarbodiimide (DCCD) were applied. DCCD 
is a specific inhibitor of ATP synthase, and inhibits ATP 
synthase by blocking the proton flux [38]. Both sodium 
azide and DCCD were used at low concentrations that 
caused negligible changes in the endogenous ATP level 
in parental LECs. However, the same dose of sodium 
azide and DCCD resulted in a nearly 30% reduction 
of endogenous ATP levels in TLECs (Figure 4A). 
Our data indicate that ATP synthase is important for 
ATP production in B[a]P/arsenic-transformed TLECs. 
Figure 2(Continued ): D. and E. are enzymatic activities of ATP synthase and OXPHOS complex I in mitochondrial homogenates 
extracted from LECs or LECs, respectively. The amounts of protein from mitochondrial homogenate used for complex I was 20 μg and ATP 
synthase was 100 μg. Data are expressed as mean ± SD. P-value (Student’s t-test) <0.05 was considered significant. 
(continued )
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Reduced ATP levels dramatically lowered the ability 
of TLECs to grow independently in soft agar (Figure 
4B), indicating inhibition of ATP synthesis was able to 
inhibit the in-vitro transforming ability of TLECs. Higher 
expression of apoptotic proteins, such as cleaved caspase 
3 and cleaved PARP, were found in TLECs in response to 
DCCD treatment, but not in parental LECs (Figure 4C), 
suggesting that reductions in ATP level in TLECs lead to 
apoptosis.
Ability to switch to glycolysis under hypoxia
Recently we reported that TLECs display a high 
level of reactive oxygen species (ROS) compared to LEC 
cells [39]. Here, we also show an increase of antioxidants 
and hypoxia inducible factor-1α (HIF-1α) in TLECs 
(Figure 2D). It has been demonstrated that increasing 
the level of ROS could, through HIF-1, regulate gene 
expression involved in glycolysis in response to hypoxia 
[40]. Under hypoxic conditions, oxygen supply is limited 
and OXPHOS is hampered. Most cancer cells will rely 
more on glycolysis for energy production under hypoxia. 
Our findings showed that TLECs rely on both OXPHOS 
and glycolysis under normoxia. To examine if TLECs 
could survive better under hypoxic conditions, cells were 
cultured under 2% oxygen and cellular viability was 
determined. Our data, shown in Figure 5A, indicate that 
the viability of TLECs was higher (80%) as compared to 
LECs (50%) under 1% oxygen, suggesting that TLECs are 
more adaptable to hypoxic conditions and can maintain 
energy production to support their growth. To determine 
if TLECs could switch to anaerobic glycolysis under 
hypoxia, LDH activity was measured. LDH is the enzyme 
responsible for the conversion of pyruvate to lactate under 
anaerobic glycolysis [33]. LDH activity can therefore 
reflect the degree of anaerobic glycolysis. Parental LECs 
only showed a small increase of LDH activity, whereas 
a surge of LDH activity was observed in TLECs under 
decreasing concentrations of oxygen content (Figure 5B), 
indicating that TLECs were able to stimulate anaerobic 
glycolysis rapidly under hypoxia.
To further determine which of two energy 
production pathways, glycolysis and OXPHOS, LECs 
and TLECs rely on more during hypoxic conditions, 
Figure 2(Continued ): F. and G. are immunoblots of glycolytic and OXPHOS enzymes in various transformed cell subclones (TMCs).
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Figure 3: Effects of 2-DG and sodium azide on cell viability of LECs and TLECs. 2DG is an inhibitor of glycolysis and 
sodium azide is an inhibitor of OXPHOS. Cell viability decreased as increasing concentrations of A. 2DG or B. sodium azide were added to 
cell culture medium for 24 h. TLECs showed significant cell death at concentrations of sodium azide higher than 2 mM. Cell viability was 
determined by NBB staining as described in the Materials and Methods section (*, p < 0.05 compared to LECs at the same concentration; 
**, p < 0.001 compared to LECs at the same concentration; ##, p < 0.001 TLECs at concentration of 1 mM sodium azide). C. Immunoblots 
of PGAM and OGDH enzymes in various transformed cell subclones.
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cellular viability was examined after addition various 
amounts of the glycolysis inhibitor 2DG or OXPHOS 
inhibitor sodium azide to media of cells cultured under 
2% oxygen. As shown in Figure 5C and 5D, TLECs 
showed significant cell death as compared to LEC when 
cells treated with sodium azide concentrations higher 
than 2 mM.
Next we examined the expression levels of HIF-
1α in LECs during the course of transformation process 
induced by B[a]P/arsenic. As shown in Figure 5E, the 
expression level of HIF-1α increased initially, then 
decreased at the mid-stage of transformation. The level of 
HIF-1α started to increase again at 10th-week of treatment 
and continued to stay at a high level.
DISCUSSION
Induced glycolysis and OXPHOS were observed 
in B[a]P/arsenic-transformed cells
Chronic B[a]P and arsenic co-exposure is still 
common in developing countries [5, 6, 11]. It has been 
known for many years that chronic arsenic exposure is 
associated with a rising incidence of cancer [10]. However, 
the underlying mechanisms are still unclear. Our previous 
data showed that combined action of arsenic and B[a]P 
is 100-fold more tumorigenic than B[a]P or arsenic alone 
[18, 19]. Thus, studies examining arsenic alone are not 
comprehensive and may not provide a full explanation for 
Figure 4: Reduction of cellular ATP content induces expression of apoptotic proteins and reduces tumorigenicity in 
TLECs. A. Endogenous ATP content was determined by an ATP kit as described in the Materials and Methods. TLECs showed elevated 
endogenous ATP levels compared to parental LECs. DCCD is an inhibitor of ATP synthase and can inhibit ATP production from oxidative 
phosphorylation. Application of a low dose of sodium azide (5 mM, 24 h) and DCCD (50 μM, 24 h) independently reduced endogenous ATP 
levels of TLECs, but parental LECs showed negligible change. B. TLECs were treated with sodium azide (5 mM) or DCCD (50 μM) for 
24 h. Cells were collected and allowed to grow in soft agar for four weeks. Only colonies with a diameter larger than 60 μm were counted. 
The number of colonies was determined from an average of 8 random fields. Inhibition of ATP production reduced the tumorigenicity of 
TLECs, as indicated by reduced ability for anchorage-independent growth. (*, p < 0.05 compared to LECs at the same concentration of 
either sodium azide or DCCP; **, p < 0.001 compared to LECs; #, p < 0.05 compare to TLECs when only vehicle was added.) C. Protein 
lysate after DCCD (50 μM, 24 h) treatment was subjected to western blot analysis. Proteins were probed for apoptotic markers cleaved 
caspase 3 and cleaved PARP. Membranes were stripped and re-probed with actin antibody to monitor loading differences. Inhibition of ATP 
production induced expression of cleaved caspase 3 and cleaved PARP in TLECs, but not in parental LECs.
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the observed effect of arsenic. Here we have established 
a TLEC model in which B[a]P-initiated LECs are made 
tumorigenic by chronic exposure to low doses of sodium 
arsenite [18, 19]. This cell model is closer to the real 
situation found in developing countries.
This study, as well as our previous results [18], 
shows that glucose metabolism is up-regulated in TLECs, 
as is evident by induced expression of glycolytic enzymes 
(Figure 2B). Consistent with this finding, a later report 
also found that arsenic exposure can induce the Warburg 
effect in cultured cells [34]. TLECs exhibit profound 
bioenergetic and histological differences as compared to 
their non-transformed counterpart. All these modifications 
are associated with increasing of cell growth, inhibition of 
apoptosis and intense anabolism.
Figure 5: Effects of hypoxia on glycolysis and viability of TLECs. A. LEC and TLEC cells were placed in a hypoxic incubator 
(under 2% oxygen) for 24 h. Cell viability was determined by NBB staining. TLECs were more adapted to hypoxic environment and showed 
higher cell viability than LECs. B. Both LEC and TLEC cells were incubated in various oxygen concentrations for 24 h, respectively, and 
glycolytic activity was determined by LDH assay. LDH activity is reflective of the level of anaerobic respiration. TLECs showed a higher 
LDH surge compared to parental LECs, indicating TLECs could rapidly induce glycolysis under hypoxia (*, p < 0.05 compared to LECs; 
**, p < 0.001 compared to LECs at the same oxygen percentage; #, p < 0.05 compared to TLECs when the oxygen percentage was set 
at 5%; ##, p < 0.001 compared to TLECs when the oxygen percentage was set at 5%). Both LEC and TLEC Cells were put in a hypoxic 
incubator (under 2% oxygen) for 24 h. 
(continued )
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The Warburg effect was discovered almost a 
century ago and in this hypothesis, cancer cells prefer 
to produce energy by upregulating glycolysis rather 
than OXPHOS, even when the oxygen supply is not 
limited [20]. Warburg proposed that aerobic glycolysis 
in cancer cells is due to a permanent impairment of 
mitochondrial OXPHOS [41]. Recently, however, many 
investigators found that the function of mitochondrial 
OXPHOS in most cancers is intact [42–47], and 
OXPHOS is preferentially stimulated in some cancer 
cells [27, 28]. Aerobic glycolysis in many cancers may 
be caused by various (Figure 6). Several investigators 
also have suggested that the Warburg effect in cancer 
is due to enhanced glycolysis suppressing OXPHOS 
rather than defects in mitochondrial OXPHOS. If 
glycolysis is suppressed in cancer cells, the function of 
Figure 5(Continued ): Cell viability decreased as increasing concentrations of C. 2DG or D. sodium azide were added to cell culture 
medium for 24 h. TLECs showed signification cell death at concentrations of sodium azide higher than 2 mM. Cell viability was determined 
by NBB staining as described in the Materials and Methods section (*, p < 0.05 compared to LECs at the same concentration; **, p < 0.001 
compared to LECs at the same concentration). 
(continued )
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mitochondrial OXPHOS should be able to be restored 
[28, 37, 44, 48]. Reitzer and colleagues [49] have 
demonstrated that OXPHOS is used preferentially to 
produce ATP in cervical carcinoma cells. Griguer et 
al. further identified two types of glioma cell lines, i.e. 
glycolytic and OXPHOS gliomas [43]. This flexibility 
in the interplay between glycolysis and OXPHOS 
in cancer cells is required by the mechanisms of 
energy production to respond to microenvironmental 
changes, as well as differences in tumor energy needs 
or biosynthetic activity. The present study also shows 
that within TLEC tumors are different transformed 
cells with various metabolic phenotypes (Figure 2F 
and 2G), indicating different subclones of transformed 
cells within TLEC benefit each other in metabolism and 
form a metabolic symbiont. Some cloned transformed 
LECs (TMC cells) demonstrate a reduction in oxidative 
phosphorylation (OXPHOS) capacity, whereas other 
TMCs express up-regulation of OXPHOS components 
(Figure 2F and 2G). This difference in bioenergetic 
types of TMCs can be explained by differences in 
microenvironment, hypoxia conditions, and the 
sequence of oncogenic activation and tumor suppressor 
gene inactivation during carcinogenesis and tumor 
progression (Figure 6). This switch is also observed at 
the level of glutamine oxidation, as shown by increasing 
OGDH enzyme activity (Figure 2E and Figure 3C). In 
sum, we might consider that OXPHOS and glycolysis 
cooperate to sustain energy needs during tumorigenesis, 
as clearly shown in Figure 3C. Recently Smolkova and 
colleagues also demonstrated waves of suppression and 
then restoration of oxidative phosphorylation in cancer 
cells [37].
It is now known that cancer cell preferences for 
glycolysis are due to the rapid production of energy [41] 
rather than going through OXPHOS. However, that the 
question arises as to whether up-regulation of glycolysis 
is the best way for cancer cells to produce energy. In 
the present study, we show that both glycolysis and 
OXPHOS are up-regulated in TLECs (Figures 2C, 2D 
and 2E). This finding suggests that these two metabolic 
pathways are not mutually exclusive. We hypothesize 
that stimulation of both glycolysis and OXPHOS will 
provide more energy in a shorter time to meet the high 
energy demand for cancer cells, which is especially 
important for those cancers that have intrinsic defects in 
energy production.
OXPHOS is at least partially intact in B[a]P/
arsenic-transformed cells
Arsenic is known to inhibit OXPHOS. Arsenic can 
inhibit pyruvate dehydrogenase [50, 51], which converts 
pyruvate to acetyl-CoA, the substrate of OXPHOS. 
Arsenic can also inhibit succinic dehydrogenase [52], the 
complex II of the electron transport chain. Arsenic is a 
phosphate analog [53] that can uncouple OXPHOS and 
reduce energy production. On the contrary, cancer cells 
require high energy production to support their rapid 
growth and expansion. Arsenic-exposed cells need to find 
a way to overcome an intrinsic energy deficient problem 
before undergoing transformation. The initial clue we 
had, from a previous independent proteomic study, was 
that stimulation of glycolysis compensates for reduced 
OXPHOS [34]. Our proteomic study and enzymatic 
activity assays show that enzymes involved in OXPHOS 
are also up-regulated in TLECs (Figure 2C and 2E). To 
validate that OXPHOS is at least partially intact in TLECs, 
two additional enzymes, SCO2 and OGDH (Figure 2F and 
2G), involved in the process were also studied. In sum, 
our data suggests that OXPHOS is functioning in TLECs. 
We hypothesize that chronic exposure to low dose arsenic 
does not completely inhibit OXPHOS, but may hamper 
the process. Up-regulation of ATP synthase by TLECs 
may compensate for the energy loss induced by arsenic 
(Figure 2B and 2D).
Figure 5(Continued ): E. Immunoblotting of HIF-1α in LEC cells at various time points during the transformation process. Total cellular 
proteins of LECs at various time points were subjected to western blot analysis with HIF-1α antibody. After development, the membrane 
was stripped and re-probed with an actin monoclonal antibody to monitor the loading difference.
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B[a]P/arsenic-transformed cells are able to 
further stimulate glycolysis in hypoxia
Energy production in a hypoxic environment 
relies mainly on glycolysis, rather than OXPHOS, due to 
the limited supply of oxygen [23, 54–57]. HIFs induce 
transcription factors to expedite cellular adaptation to 
hypoxic environments and play critical roles in shifting 
from the OXPHOS to the glycolytic phenotype in cancer 
[58–61]. HIF-1α regulates more than one hundred different 
genes, including GLUT1 and GLUT3, and up-regulates 
nine of the ten glycolytic enzymes [62]. It also activates 
pyruvate dehydrogenase kinase 1 (PDK1), which inhibits 
the conversion of pyruvate to acetyl CoA and therefore 
decreases mitochondrial OXPHOS. Significantly, a recent 
study demonstrated that pyruvate kinase M2 (PKM2) gene 
transcription is also activated by HIF-1α [63]. PKM2 is 
critical for aerobic glycolysis and tumor growth [64]. M type 
pyruvate kinase (PK) has two isoforms: PKM1 and PKM2. 
PKM1 is expressed in most adult tissue, whereas PKM2 is 
only expressed in embryonic and proliferating tissues.
Previously, our laboratory demonstrated an 
increased level of ROS during LEC transformation 
induced by B[a]P/arsenic [29, 65]. ROS subsequently 
induced HIF-1α. HIF-1α, in turn, stimulated the expression 
of glycolytic enzymes and glucose transporters Glut 1 and 
Glut 3. In the present study, we found that TLECs could 
undergo a further stimulation of glycolysis, in a hypoxic 
environment, compared to parental LECs, indicating 
TLECs are versatile in selecting metabolic processes to 
meet their energy demand and maintain growth. When 
TLECs are located in well-oxygenated conditions, they 
express aerobic glycolysis. However, when TLECs are 
present under hypoxic conditions, hypoxia promotes 
“anaerobic glycolysis” through HIF-1α-dependent up-
regulation. Cells using aerobic or anaerobic glycolysis 
survive only in case they extrude acidic metabolites 
acidifying the extracellular space. Acidosis drives 
TLECs from glycolysis to OXPHOS. Therefore, TLECs 
are more resistant to the glycolysis inhibitor 2-DG and 
more sensitive to the OXPHOS inhibitor sodium azide 
(Figures 3A and 3B, Figures 5C and 5D). The ability of 
OXPHOS inhibition (e.g. sodium azide) to preferentially 
kill transformed cells (TLECs) in a hypoxic environment 
provides a biochemical basis to further develop this class 
of compounds as novel anticancer therapeutic agents.
In conclusion, the present study expands our 
understanding of energy producing pathways in B[a]P/
Figure 6: TLECs show interplay between glycolysis and OXPHOS to produce ATP. In LECs, OXPHOS is the major source for 
ATP production. However, TLECs shifted from OXPHOS to glycolysis for the production of energy (Warburg effect). The increased level 
of ROS production in TLECs has been shown to inhibit prolyl hydroxylase enzyme (PHD) activity, thus preventing HIF-1α proteasomal 
degradation. Consequently, HIF-1α is stabilized and translocates to the nucleus, where it dimerizes with HIF-1β, initiating the transcription 
of HIF-1 responsiveness genes including most of the glycolytic enzymes that promote glycolysis in TLECs. However, in response to 
different microenvironments, hypoxia conditions, and the sequence of oncogenic activation and tumor suppressor gene inactivation, TLECs 
may express upregulation of OXPHOS components.
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arsenic-transformed TLEC cells. In addition to stimulation 
of glycolysis, TLECs can also up-regulate OXPHOS to 
enhance energy production for growth and expansion 
during carcinogenesis. Our study demonstrates that TLECs 
can rapidly stimulate further induction of glycolysis 
under hypoxia, providing a growth advantage in a hostile 
environment. Alteration of energy metabolism in cancer 
cells may be a therapeutic target of choice. Understanding 
the features and complexity of the cancer energy metabolic 
profile may help to develop new approaches in early 
diagnosis and effectively target therapy of cancer.
EXPERIMENTAL PROCEDURES
Cell culture
Rat lung epithelial cells (LECs) [29] were cultured 
in F-12 medium (GIBCO-BRL, Grand Island, NY) 
supplemented with 1.6 g/L sodium bicarbonate (Sigma, 
St. Louis, MO), 10% (v/v) fetal bovine serum (FBS, 
GIBCO, Invitrogen, Carlsbad, CA) and 100 U/ml 
penicillin- streptomycin (GIBCO-BRL). Cultures were 
maintained in a humidified incubator with 95% air and 
5% CO
2
 at 37°C. For hypoxia experiments, cells were 
cultured under 1%, 2%, or 5% oxygen for various times 
at 37°C. 2-Deoxy-D-glucose (2DG, Sigma, St. Louis, 
MO) and sodium azide (NaN3, Sigma) were dissolved in 
Milli-Q water and filtered through a 0.22 μM membrane 
for sterilization. N,N’-dicyclohexylcarbodiimide (DCCD, 
Sigma) was dissolved in DMSO and filtered through a 
0.22 μM membrane. Designated concentrations of each 
inhibitor were added to cells for the indicated times.
Arsenite-induced in vitro cell transformation
Transformation of LECs was performed as described 
in our previous paper [18]. Briefly, LECs were cultured in 
medium with 100 nM benzo[α]pyrene (Sigma, St. Louis, 
MO) for 24 h. Then medium was replaced with medium 
containing 2 μM sodium arsenite (Sigma). These LECs 
were allowed to grow in the arsenite-containing medium 
for 12 weeks. Cell transformation was determined by 
capacity for anchorage-independent growth and in-vivo 
tumor formation in nude mice. For tumor formation 
in nude mice, 5 x 106 LECs or TLECs were inoculated 
subcutaneously into 3- to 4-week-old female Nu/Nu nude 
mice. Tumor formation was assessed every three days for 
five weeks. This nude mouse tumorigenicity assay was 
repeated three times with 5 mice in each group.
Western blotting
Western blot analysis was performed as described 
[30]. Fifteen μg total protein lysate was separated on 10% 
SDS-PAGE. Proteins were then transferred to a PVDF 
membrane (Amersham Biosciences, Piscataway, NJ). 
The membrane was blocked, incubated with primary 
antibodies overnight and secondary antibody for 1 h 
at room temperature. The membrane was developed 
with ECL Plus chemiluminescence reagent (Amersham 
Biosciences). The primary antibodies used in this study 
were against actin (Santa Cruz, CA), peripherin (Santa 
Cruz, CA), cytokeratin-8 (Abcam, MA), aldose reductase 
(Abcam, MA), alpha-enolase (Santa Cruz, CA), Grp75 
(Cell Signaling Technology, MA), phosphoglycerate 
mutase (Santa Cruz, CA), F1 ATPase (Santa Cruz, CA), 
SCO2 (Santa Cruz, CA) and OGDH (Santa Cruz, CA).
Proteomic study
Two-dimensional electrophoresis, tryptic in-gel 
digestion and MALDI-TOF-MS analysis were conducted 
by following a protocol described previously [31]. Briefly, 
300 μg whole cellular lysate was diluted in rehydration 
solutions containing a trace amount of bromophenol blue. 
Isoelectric focusing (IEF) was carried out with precast 
13 cm ImmobilineDryStrips (IPG strips, Amersham 
Biosciences) to generate a non-linear pH gradient of 
3-10. Following IEF, strips were immediately used for the 
second dimension SDS-PAGE. Proteins were visualized 
with silver stain, and two-dimensional gels were scanned 
by using an Image Scanner (Amersham Biosciences), 
operated by LabScan 3.00 software. Intensity calibration 
was performed with an intensity step wedge prior to 
gel image capture. Image analysis was carried out by 
ImageMaster 2D Elite software 4.01. Only up-/down-
regulated spots (± over 1.5-fold) or spots that either 
appeared or disappeared were selected for tryptic in-gel 
digestion followed by analysis with a mass spectrometer 
(MS).
Cell viability assay
Cell viability was measured by a naphthol blue black 
(NBB) staining assay [32]. Cells were plated in 96-well 
plates at a density of 2 x 104 per well. Cells were treated 
under various conditions at the indicated times. At the end 
of the experiment, cells were fixed in 10% formalin for 10 
min and stained with NBB solution (0.05% NBB in 9% 
acetic acid with 0.1 M sodium acetate) for 30 min at room 
temperature. Fixed cells were washed three times with 
water to remove free dye. The attached dye was eluted 
with 150 μl of 50 mM NaOH. The optical density at 595 
nm was measured using a Model EI 310 Autoplate reader 
(Bio-Tek Instrument, Winooski, VT).
Enzyme activity assays
The enzymatic activity of ATP synthase, which 
is responsible for ATP generation, was also assessed in 
the LECs and TLECs using an ATP Synthase Enzyme 
Activity Microplate Assay Kit (ab109714, Abcam, 
Cambridge, MA, USA) according to the manufacturer’s 
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protocol. Briefly, ATP synthase from each cell culture 
was selectively immunocaptured in the microplate 
wells, and the ability of the captured ATP synthetase to 
synthesize ATP was determined by detecting the change in 
absorbance at 340 nm using a microplate reader (Synergy 
HT, BioTek, VT). These activities were expressed as a 
change in absorbance per minute per milligram of protein.
Complex I activities were analyzed using the 
Complex I Enzyme Activity Microplate Assay kit 
(ab109721, Abcam, Cambridge, MA). The complex I 
activity was measured by following the oxidation of 
NADH to NAD+ and the simultaneous reduction of a dye 
which leads to increased absorbance at 450 nm.
Measurement of cellular ATP content
ATP concentration was determined by an ATP kit 
according to manufacturer’s protocol (PerkinElmer, 
Boston, MA). Briefly, cells were cultured in 96-well plates 
at density 5 x 103 cells/well. ATP inhibitors were added 
to the wells. At the end of the incubation period, 50 μl 
of mammalian cell lysis solution provided in the kit was 
added to the culture medium and the plate was shaken for 
5 min in the dark. Fifty μl substrate solution was added 
into each well. The plate was shaken for 5 min in the dark, 
and then luminescence was measured by a plate reader.
Measurement of glycolytic activity
Cellular glycolytic activity was determined 
by measuring the activity of the key enzyme, lactate 
dehydrogenase (LDH). The activity of lactate 
dehydrogenase was monitored spectrophotometrically 
by the increase in NADH at 340 nm when pyruvate 
was converted to lactate [33]. Lactate concentration in 
the culture medium was measured using commercial 
chromatometric kits from Sigma (St. Louis, MO).
Statistical analysis
Statistical analysis was performed by using a two-
tailed Student’s t-test, and a p < 0.05 was considered 
significant. Data are expressed as the mean ± SD of 
triplicate samples, and the reproducibility was confirmed 
in three separate experiments.
Abbreviations
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